Solution-based studies on the contact between the complement receptor 3 ligand-binding domain and simvastatin
{{output}}
Simvastatin is a primary cholesterol-lowering medication, but it has also been reported to possess anti-inflammatory properties. Notably, the CD18 integrins are targets for simvastatin antagonism of ligand binding, which may affect leukocyte adhesion and diape... ...
